PNC FINANCIAL SERVICES GROUP, INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$115,000
-12.2%
530
-53.1%
0.00%
Q4 2020$131,000
+52.3%
1,130
+27.0%
0.00%
Q3 2020$86,000
-27.1%
890
-6.9%
0.00%
Q2 2020$118,000
+53.2%
956
+7.4%
0.00%
Q1 2020$77,000
+14.9%
890
+39.1%
0.00%
Q4 2019$67,000
+86.1%
640
+103.2%
0.00%
Q3 2019$36,000
-50.0%
315
-24.1%
0.00%
Q2 2019$72,000
-10.0%
415
-12.3%
0.00%
Q1 2019$80,000
+196.3%
473
+68.9%
0.00%
Q4 2018$27,000
-64.9%
280
-37.1%
0.00%
Q3 2018$77,000
+71.1%
445
+39.1%
0.00%
Q2 2018$45,000
+73.1%
320
+39.1%
0.00%
Q1 2018$26,000
-18.8%
230
-8.4%
0.00%
Q4 2017$32,000
+39.1%
251
+9.1%
0.00%
Q3 2017$23,0000.0%2300.0%0.00%
Q2 2017$23,000
-17.9%
2300.0%0.00%
Q1 2017$28,000
+86.7%
230
+76.9%
0.00%
Q4 2016$15,000
-48.3%
130
-40.1%
0.00%
Q3 2016$29,000
+141.7%
217
+66.9%
0.00%
Q2 2016$12,000
+33.3%
1300.0%0.00%
Q1 2016$9,000
-18.2%
130
-18.8%
0.00%
Q4 2015$11,000
-8.3%
160
+23.1%
0.00%
Q3 2015$12,000
-98.5%
130
-98.0%
0.00%
-100.0%
Q2 2015$814,000
+31.3%
6,630
-2.6%
0.00%0.0%
Q1 2015$620,000
+45.2%
6,807
+7.9%
0.00%
Q4 2014$427,000
+130.8%
6,307
+175.4%
0.00%
Q3 2014$185,000
+115.1%
2,290
+186.2%
0.00%
Q2 2014$86,0008000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders